Your browser doesn't support javascript.
loading
AAT: does it have a place in acute leukemia?
Dogu, Mehmet H; Ozcelik, Berfin; Akbulut, Yusuf E; Kantarci, Mert; Bektas, Ezgi; Serin, Istemi.
Afiliación
  • Dogu MH; Department of Hematology, Istinye University, Faculty of Medicine, Liv Hospital Ulus, Ulus-Istanbul, 34340, Turkey.
  • Ozcelik B; Department of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Fatih-Istanbul, 34098, Turkey.
  • Akbulut YE; Department of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Fatih-Istanbul, 34098, Turkey.
  • Kantarci M; Department of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Fatih-Istanbul, 34098, Turkey.
  • Bektas E; Department of Internal Medicine, University of Health Sciences, Istanbul Training and Research Hospital, Fatih-Istanbul, 34098, Turkey.
  • Serin I; Department of Hematology, University of Health Sciences, Istanbul Training and Research Hospital, Fatih-Istanbul, 34098, Turkey.
Biomark Med ; 17(18): 747-754, 2023 09.
Article en En | MEDLINE | ID: mdl-38197403
ABSTRACT

Aim:

In this study, the authors aimed to investigate the change of AAT, its effect on the response to induction and its effects on the treatment process in acute myeloid leukemia and acute lymphoblastic leukemia patients. Materials &

methods:

This study included 94 patients who were hospitalized and followed up in Istanbul Training and Research Hospital, Hematology Clinic, between October 2019 and December 2021.

Results:

Patients with a complete response had higher serum AAT levels than those with a non-complete response (p < 0.05). The mean serum AAT level was found to be significantly higher in patients without Gram-positive growth than in patients with Gram-positive growth.

Conclusion:

It can be thought that AAT can play a role during the course of acute leukemia management.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia Mieloide Aguda / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Diagnostic_studies Idioma: En Revista: Biomark Med Asunto de la revista: BIOQUIMICA / MEDICINA Año: 2023 Tipo del documento: Article